PubMed Health⌕ Search

PubMed · 11797902

Too many notes?

Abstract

Orphan sources are now recognized as a radiation protection problem needing attention. Government and private sector initiatives have been mounted in response. Should more be done? There are promising possibilities. Under the ICRP 60 system of radiation protection, any use of radiation should be justified. Key NRC licensing regulations predate ICRP 60 and, consequently, if a use is authorized by license, then the use is presumed to be justified even if alternatives are available. As an example, x-ray gauges can be successfully substituted for nuclear container fill level gauges in the food and beverage industry. But this development is not widely known to potential users and regulators, and current regulatory policies do not address this. Limiting the number of radioactive devices would limit the number of potential orphan sources. From an operational radiation safety point of view, persons wanting to dispose of unneeded or unwanted radioactive sources are faced with a system loaded with disincentives, in part because disposition options are not well known and in part because options have become limited, complex, and expensive. New approaches are needed if the orphan source problem is to be effectively addressed. Paramount are the needs to (1) update U.S. regulatory policies to incorporate the ICRP principle of justification, (2) create a system that encourages prompt, safe dispositioning of unneeded and unwanted radioactive sources, and (3) make information on these points universally known to users of radioactive sources.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Joel O Lubenau. 2002. Too many notes?. https://doi.org/10.1097/00004032-200202001-00009

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗